Dry Eye Therapy
What is the OptiLight?
The OptiLight is the only FDA-approved light therapy (IPL) for managing dry eye disease due to MGD (meibomian gland deficiency). The OptiLight uses precise broad-spectrum light to address signs of dry eye disease caused by MGD, the most common cause of dry eye. The OptiLight is a precise and comfortable dry eye procedure developed to reach the delicate contours below the eye and reduce inflammation.
How the OptiLight helps alleviate Dry Eye
Reduces inflammatory mediators
Improves tear breakup time
Alleviates abnormal blood vessels
Restores Meibomian glands
What to expect
The treatment is facilitated in 4 sessions spaced 2–4 weeks apart; each session only takes 10–15 minutes. During treatment, Dr. Hofacre will cover your eyes with a protective shield and apply a thin layer of gel on the treatment area. Then, the OptiLight is applied to the skin below the eyes. The treatment is non-invasive, you’ll feel a warm sensation of light with minimal discomfort. Most patients can return to regular activities after treatment and expect to see improvement after the 2nd or 3rd session.